[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 724 Introduced in Senate (IS)]
<DOC>
116th CONGRESS
1st Session
S. 724
To amend the Controlled Substances Act to establish additional
registration requirements for prescribers of opioids, and for other
purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
March 7, 2019
Mrs. Gillibrand (for herself and Mr. Gardner) introduced the following
bill; which was read twice and referred to the Committee on the
Judiciary
_______________________________________________________________________
A BILL
To amend the Controlled Substances Act to establish additional
registration requirements for prescribers of opioids, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``John S. McCain Opioid Addiction
Prevention Act''.
SEC. 2. REGISTRATION REQUIREMENTS FOR PRESCRIBERS.
Section 303 of the Controlled Substances Act (21 U.S.C. 823) is
amended by adding at the end the following:
``(l)(1) Creating obligations for practitioners, only as described
herein, the Attorney General shall not register, or renew the
registration of, a practitioner under subsection (f) who is licensed
under State law to prescribe controlled substances in schedule II, III,
or IV, unless the practitioner submits to the Attorney General, for
each such registration or renewal request, a certification that the
practitioner, during the applicable registration period, will not
prescribe any schedule II, III, or IV opioid, other than an opioid
prescription described in paragraph (3), for the initial treatment of
acute pain in an amount in excess of the lesser of--
``(A) a 7-day supply (for which no refill is available); or
``(B) an opioid prescription limit established under State
law.
``(2) In this subsection, the term `acute pain'--
``(A) means pain with abrupt onset and caused by an injury
or other process that is not ongoing; and
``(B) does not include--
``(i) chronic pain;
``(ii) pain being treated as part of cancer care;
``(iii) hospice or other end-of-life care; or
``(iv) pain being treated as part of palliative
care.
``(3) An opioid prescription described in this paragraph is a
prescription--
``(A) for a schedule II, III, or IV opioid drug approved by
the Food and Drug Administration for an indication for the
treatment of addiction; and
``(B) that is for the treatment of addiction.''.
<all>